Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-11-30
1991-12-17
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
574382, 574397, 574398, 548253, 548336, 548337, C07D23344, C07D, A61K 3141, A61K 3134
Patent
active
050735667
ABSTRACT:
This invention provides novel phenyl and heterocyclic derivatives, their pharmaceutical formulations and their use for antagonizing angiotensin II receptors in mammals.
REFERENCES:
patent: 3772315 (1973-11-01), Regel et al.
patent: 4089962 (1978-05-01), Harrison et al.
patent: 4207324 (1980-06-01), Matsumura et al.
patent: 4226878 (1980-10-01), Iizuka et al.
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4379927 (1983-04-01), Vorbruggen et al.
patent: 4448781 (1984-05-01), Cross et al.
patent: 4528195 (1985-07-01), Thorogood et al.
patent: 4582847 (1986-04-01), Furukawa et al.
patent: 4584383 (1986-04-01), Parhi
patent: 4908363 (1990-03-01), Klotzer et al.
patent: 4916129 (1990-04-01), Carini et al.
Wong et al, J. Pharm. Exptl. Ther., 247 (1), 1 (1988).
Lifer Sherryl L.
Marshall Winston S.
Mohamadi Fariborz
Reel Jon K.
Simon Richard L.
Conrad Robert A.
Eli Lilly and Company
Springer David B.
Whitaker Leroy
LandOfFree
Angiotensin II antagonist 1,3-imidazoles and use thereas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II antagonist 1,3-imidazoles and use thereas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II antagonist 1,3-imidazoles and use thereas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-835853